Onconetix (ONCO) Tax Rate (2024)
Onconetix (ONCO) posted quarterly Tax Rate of 0.44% for Q4 2024, down 130.36% quarter-over-quarter from 1.45% in Q3 2024.
Onconetix (ONCO) Tax Rate (2024) Analysis & Trends
Onconetix (ONCO) has reported Tax Rate for 1 consecutive years, with 0.44% the latest figure, recorded in Q4 2024.
- In Q4 2024, Tax Rate changed N/A year-over-year to 0.44%; the TTM figure through Dec 2024 stood at 33.88% (changed N/A YoY), while the FY2025 annual figure was 0.07%, down 3395.0% from the prior year.
- Tax Rate fell to 0.44% in Q4 2024 per ONCO's latest filing, from 1.45% in the prior quarter.
- Across five years, Tax Rate topped out at 1.45% in Q3 2024 and bottomed at 0.44% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | - |
| 10 | Onconetix | 1.45 Mn | -4.50 Mn | 4,303.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.44% |
| Dec 31, 2024 | -0.44% |
| Dec 31, 2024 | -0.44% |
| Sep 30, 2024 | 1.45% |
| Sep 30, 2024 | 1.45% |
| Sep 30, 2024 | 1.45% |
| Jun 30, 2024 | -0.36% |
| Jun 30, 2024 | -0.36% |
| Jun 30, 2024 | -0.36% |
| Mar 31, 2024 | 1.08% |
| Mar 31, 2024 | 1.08% |
| Mar 31, 2024 | 1.08% |